Drug Name: | Xamoterol (81801-12-9) |
---|---|
PubChem ID: | 155774 |
SMILES: | C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O |
InchiKey: | DXPOSRCHIDYWHW-UHFFFAOYSA-N |
Therapeutic Category: |
Molecular Weight (dalton) | : | 339.392 |
LogP | : | -0.2367 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 6 |
Hydrogen Bond Donor Count | : | 4 |
Total Polar Surface Area | : | 103.29 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|---|---|---|
Beta-Blockade | CYP2D6 (P10635) | Increased beta-blockade [ ADR Type 1 ] | Drugs in special patient groups: clinical importance of genomics in drug effects In: Carruthers GS, Hoffmann BB,Melmon KL, Nierenberg DW |
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category
Toxicity | Source |
---|---|
Atrial Fibrillation | MetaADEDB |
Heart Failure | MetaADEDB |
Tachycardia | MetaADEDB |